CSF2 and prostate cancer: Talimogene laherparepvec (T-VEC) is an oncolytic virus for melanoma which encodes GM-CSF and sipuleucel-T, an autologous DC infusion for prostate cancer, stimulated ex vivo with a tumour-associated antigen fused to GM-CSF [207,208].